This peptide targets the DSG2 cell adhesion recognition (CAR) domain and has been previously demonstrated to block DSG2-mediated alveolar morphogenesis by epithelial cells [34] and colon carcinoma cell aggregation [35]. Here, DSG2 is linked to colon carcinoma.